Performance analysis of Viridian Therapeutics (VRDN)
Annual Return
Over the past 3 years, VRDN has had an average annual return of -12.41%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, VRDN has had an average annual return of +0.51%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, VRDN has had an average annual return of -18.47%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Jun 18, 2014, VRDN has had an average annual return of -33.20%, underperforming the benchmark SPY, which returned +13.83% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -47.37% | +61.70% | -11.32% | -25.87% | +47.42% | +21.25% | +128.57% | -84.23% | -70.98% | +108.45% | -55.41% | -70.54% |
| 2014 | |||||||||||
| -72.06% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.92% | -10.56% | -33.33% | -31.25% | +30.30% | -6.98% | -47.37% | ||||||
| 2025 | +1.06% | -20.00% | -13.16% | +0% | +3.03% | +0% | +26.47% | +4.65% | +17.78% | +9.43% | +34.48% | -2.56% | +61.70% |
| 2024 | -11.32% | -3.19% | -5.49% | -24.42% | -10.77% | +10.34% | +28.13% | -12.20% | +54.17% | -5.41% | +0% | -10.48% | -11.32% |
| 2023 | +25.17% | -10.61% | -22.50% | +10.48% | -14.60% | -0.85% | -20.69% | -3.26% | -15.73% | -18.67% | +34.43% | +29.27% | -25.87% |
| 2022 | +1.03% | -10.20% | +2.27% | -25.56% | -10.45% | -5.00% | +14.04% | +67.69% | -8.26% | -3.00% | +27.84% | +15.32% | +47.42% |
| 2021 | +8.75% | -8.05% | +2.50% | +8.54% | -1.12% | +1.14% | -14.61% | -14.47% | +23.08% | +10% | +6.82% | +3.19% | +21.25% |
| 2020 | +265.71% | -57.81% | -38.89% | +39.39% | +56.52% | +12.50% | -0% | -16.05% | -16.18% | +68.42% | -10.42% | -6.98% | +128.57% |
| 2019 | -5.41% | -2.38% | -0% | +4.88% | -19.07% | -13.79% | -2.00% | -42.86% | -35.71% | -12.96% | +25.53% | -40.68% | -84.23% |
| 2018 | -28.10% | -26.00% | +26.29% | -2.14% | +3.18% | -9.44% | +5.11% | -7.89% | -10.11% | -22.49% | -19.56% | -12.94% | -70.98% |
| 2017 | +81.20% | +44.51% | -5.10% | +3.84% | -15.42% | +18.35% | +5.80% | -34.20% | +1.67% | -9.54% | -3.62% | +30.77% | +108.45% |
Drawdown analysis of Viridian Therapeutics (VRDN)
The maximum drawdown for the VRDN was -99.73%, occurring on Mar 18, 2020. This drawdown has not yet recovered.
The current VRDN drawdown is -99.20%.
Since Jun 18, 2014 VRDN has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.73% | Jun 18, 2014 | 1447 | Mar 18, 2020 | Ongoing | Ongoing | Ongoing |